Clinical Trials Directory

Trials / Completed

CompletedNCT04498065

MYocardial DOmmages Related to COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
273 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Myocardial injury, as assessed by elevation of cardiac troponins (Tnc), is frequent among patients with COVID-19. Although rare autopsy cases reported COVID-19 related myocardial inflammation, the origin of Tnc elevation is unknown to date. Several cardiac causes, such as myocarditis, non-ischemic myocardial injury (NIMI), or myocardial infarction (MI) may lead to Tnc kinetic. Our work will test the hypothesis that during SARS-Cov2 infection, the elevation of cardiac biomarkers could be linked to the occurrence of myocarditis.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBiological dataBiological data
OTHERClinical dataClinical data

Timeline

Start date
2020-03-01
Primary completion
2022-05-31
Completion
2022-05-31
First posted
2020-08-04
Last updated
2022-09-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04498065. Inclusion in this directory is not an endorsement.

MYocardial DOmmages Related to COVID-19 (NCT04498065) · Clinical Trials Directory